| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.33e-09 | 4 | 122 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.33e-09 | 4 | 122 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.33e-09 | 4 | 122 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 6.60e-09 | 5 | 122 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 6.60e-09 | 5 | 122 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 6.60e-09 | 5 | 122 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 6.60e-09 | 5 | 122 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 6.60e-09 | 5 | 122 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 6.60e-09 | 5 | 122 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 6.60e-09 | 5 | 122 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.97e-08 | 6 | 122 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 4.58e-08 | 7 | 122 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 9.11e-08 | 8 | 122 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 9.11e-08 | 8 | 122 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 9.11e-08 | 8 | 122 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.63e-07 | 9 | 122 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.63e-07 | 9 | 122 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.71e-07 | 10 | 122 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.71e-07 | 10 | 122 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | NADPH binding | 4.65e-07 | 26 | 122 | 5 | GO:0070402 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.27e-06 | 14 | 122 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.27e-06 | 14 | 122 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.89e-06 | 34 | 122 | 5 | GO:0016628 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 5.96e-06 | 20 | 122 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.28e-05 | 24 | 122 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.79e-05 | 26 | 122 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.09e-05 | 27 | 122 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.21e-05 | 30 | 122 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 3.54e-05 | 11 | 122 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABRA MYH4 WASL MYH8 MYO1E CLIP2 SPTA1 RAB3D ACTR3 MPRIP STX1A BRCA1 BRCA2 XIRP2 KCNQ2 UXT SKA1 RAB3B FRMD3 | 3.75e-05 | 1099 | 122 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.84e-05 | 62 | 122 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.84e-05 | 62 | 122 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.18e-05 | 32 | 122 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.73e-05 | 33 | 122 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB35 MYH4 MYH8 SPG7 CCT3 MYO1E DHX38 RAB3D RRAD GSPT1 LONP1 DCP1B GFM1 RAB3B HSPA14 SMC1B | 5.23e-05 | 839 | 122 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB35 MYH4 MYH8 SPG7 CCT3 MYO1E DHX38 RAB3D RRAD GSPT1 LONP1 DCP1B GFM1 RAB3B HSPA14 SMC1B | 5.30e-05 | 840 | 122 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB35 MYH4 MYH8 SPG7 CCT3 MYO1E DHX38 RAB3D RRAD GSPT1 LONP1 DCP1B GFM1 RAB3B HSPA14 SMC1B | 5.30e-05 | 840 | 122 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB35 MYH4 MYH8 SPG7 CCT3 MYO1E DHX38 RAB3D RRAD GSPT1 LONP1 GFM1 RAB3B HSPA14 SMC1B | 7.73e-05 | 775 | 122 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | actin filament binding | 7.81e-05 | 227 | 122 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 9.25e-05 | 39 | 122 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.02e-04 | 40 | 122 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.10e-04 | 48 | 122 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.20e-04 | 4 | 122 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 3.66e-04 | 5 | 122 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.81e-04 | 56 | 122 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 4.97e-04 | 60 | 122 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.36e-04 | 230 | 122 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin binding | 7.22e-04 | 479 | 122 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | ATP-dependent peptidase activity | 1.01e-03 | 8 | 122 | 2 | GO:0004176 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.30e-03 | 9 | 122 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | steroid binding | 1.35e-03 | 133 | 122 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.56e-03 | 441 | 122 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.61e-03 | 38 | 122 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CAMK1D PDGFRL TSSK2 DGKD MAP3K12 POLR3A TGFBR3 MAST4 PDIK1L BTK PRKAG1 PCYT2 POLR1B PLK4 | 1.77e-03 | 938 | 122 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | myosin binding | 1.83e-03 | 85 | 122 | 4 | GO:0017022 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 1.96e-03 | 11 | 122 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.35e-03 | 12 | 122 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 2.75e-03 | 95 | 122 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.74e-03 | 51 | 122 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein kinase activity | CAMK1D PDGFRL TSSK2 MAP3K12 TGFBR3 MAST4 PDIK1L BTK PRKAG1 PLK4 | 3.78e-03 | 600 | 122 | 10 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CAMK1D PDGFRL TSSK2 DGKD MAP3K12 TGFBR3 MAST4 PDIK1L BTK PRKAG1 PLK4 | 4.14e-03 | 709 | 122 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 4.20e-03 | 16 | 122 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 4.20e-03 | 16 | 122 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 4.22e-03 | 107 | 122 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.44e-03 | 614 | 122 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.63e-03 | 55 | 122 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 5.31e-03 | 18 | 122 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 5.44e-03 | 115 | 122 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.91e-03 | 60 | 122 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 6.12e-03 | 446 | 122 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | myosin V binding | 6.55e-03 | 20 | 122 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | kinase activity | CAMK1D PDGFRL TSSK2 DGKD MAP3K12 TGFBR3 MAST4 PDIK1L BTK PRKAG1 PLK4 | 7.16e-03 | 764 | 122 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.21e-03 | 21 | 122 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 7.70e-03 | 127 | 122 | 4 | GO:0016616 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.09e-09 | 4 | 120 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.09e-09 | 4 | 120 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.09e-09 | 4 | 120 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.09e-09 | 4 | 120 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 5.42e-09 | 5 | 120 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 5.42e-09 | 5 | 120 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 5.42e-09 | 5 | 120 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 5.42e-09 | 5 | 120 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 5.42e-09 | 5 | 120 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 5.42e-09 | 5 | 120 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.62e-08 | 6 | 120 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.62e-08 | 6 | 120 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.76e-08 | 7 | 120 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.76e-08 | 7 | 120 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.76e-08 | 7 | 120 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.34e-07 | 9 | 120 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.23e-07 | 10 | 120 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 2.23e-07 | 10 | 120 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.23e-07 | 10 | 120 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.23e-07 | 10 | 120 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.23e-07 | 10 | 120 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 3.48e-07 | 11 | 120 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 3.48e-07 | 11 | 120 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.04e-06 | 14 | 120 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 1.04e-06 | 14 | 120 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 1.42e-06 | 15 | 120 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.88e-06 | 16 | 120 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.88e-06 | 16 | 120 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 2.00e-06 | 36 | 120 | 5 | GO:0034694 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 3.13e-06 | 18 | 120 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 6.04e-06 | 21 | 120 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 6.04e-06 | 21 | 120 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 6.04e-06 | 21 | 120 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 6.04e-06 | 21 | 120 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 6.04e-06 | 21 | 120 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 7.35e-06 | 22 | 120 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 7.35e-06 | 22 | 120 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 7.35e-06 | 22 | 120 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 7.35e-06 | 22 | 120 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 8.86e-06 | 23 | 120 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.86e-06 | 23 | 120 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.48e-05 | 26 | 120 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.00e-05 | 28 | 120 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.31e-05 | 29 | 120 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.31e-05 | 29 | 120 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.45e-05 | 32 | 120 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.91e-05 | 33 | 120 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 4.41e-05 | 34 | 120 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.96e-05 | 35 | 120 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 5.56e-05 | 36 | 120 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 6.90e-05 | 38 | 120 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 8.47e-05 | 40 | 120 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | peptidyl-cysteine methylation | 1.00e-04 | 3 | 120 | 2 | GO:0018125 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.03e-04 | 42 | 120 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 1.13e-04 | 130 | 120 | 6 | GO:0097306 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.35e-04 | 45 | 120 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.60e-04 | 47 | 120 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.63e-04 | 88 | 120 | 5 | GO:0071277 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.91e-04 | 91 | 120 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.91e-04 | 91 | 120 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of clathrin-dependent endocytosis | 2.37e-04 | 21 | 120 | 3 | GO:2000369 | |
| GeneOntologyBiologicalProcess | clathrin-dependent endocytosis | 2.56e-04 | 53 | 120 | 4 | GO:0072583 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 3.17e-04 | 56 | 120 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | positive regulation of clathrin-dependent endocytosis | 3.32e-04 | 5 | 120 | 2 | GO:2000370 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 3.39e-04 | 57 | 120 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 3.39e-04 | 57 | 120 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 3.63e-04 | 58 | 120 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 4.13e-04 | 60 | 120 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | muscular septum morphogenesis | 4.96e-04 | 6 | 120 | 2 | GO:0003150 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 6.29e-04 | 67 | 120 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 7.04e-04 | 69 | 120 | 4 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species metabolic process | 8.19e-04 | 188 | 120 | 6 | GO:2000377 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 8.70e-04 | 73 | 120 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 9.16e-04 | 74 | 120 | 4 | GO:2000351 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 9.50e-04 | 129 | 120 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 9.84e-04 | 130 | 120 | 5 | GO:1901655 | |
| GeneOntologyBiologicalProcess | neutrophil homeostasis | 1.10e-03 | 35 | 120 | 3 | GO:0001780 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.13e-03 | 134 | 120 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 1.17e-03 | 79 | 120 | 4 | GO:0072577 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 1.28e-03 | 81 | 120 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | membranous septum morphogenesis | 1.47e-03 | 10 | 120 | 2 | GO:0003149 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 1.47e-03 | 10 | 120 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.55e-03 | 290 | 120 | 7 | GO:0044703 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 1.60e-03 | 145 | 120 | 5 | GO:0045833 | |
| GeneOntologyBiologicalProcess | cell cycle process | RAB35 WASL KAT5 ACTR3 GSPT1 BNIP2 BRCA1 BRCA2 CTCF TPX2 BTN2A3P MKI67 PPME1 UXT SKA1 PLK4 PHIP SMC1B | 1.68e-03 | 1441 | 120 | 18 | GO:0022402 |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 1.68e-03 | 294 | 120 | 7 | GO:0044706 | |
| MousePheno | parturition failure | 6.33e-07 | 10 | 106 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 9.89e-07 | 11 | 106 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 2.12e-06 | 13 | 106 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 4.00e-06 | 15 | 106 | 4 | MP:0005186 | |
| MousePheno | long stride length | 4.00e-06 | 15 | 106 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 4.00e-06 | 15 | 106 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 8.81e-06 | 18 | 106 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 1.38e-05 | 20 | 106 | 4 | MP:0013438 | |
| MousePheno | decreased vocalization | 2.44e-05 | 46 | 106 | 5 | MP:0020351 | |
| MousePheno | decreased oligodendrocyte number | 3.49e-05 | 25 | 106 | 4 | MP:0009808 | |
| MousePheno | prolonged diestrus | 7.35e-05 | 30 | 106 | 4 | MP:0009011 | |
| MousePheno | abnormal parturition | 1.08e-04 | 33 | 106 | 4 | MP:0002907 | |
| MousePheno | enlarged stomach | 1.08e-04 | 33 | 106 | 4 | MP:0003883 | |
| MousePheno | abnormal diestrus | 1.36e-04 | 35 | 106 | 4 | MP:0009010 | |
| MousePheno | failure of bone ossification | 1.45e-04 | 14 | 106 | 3 | MP:0008274 | |
| MousePheno | abnormal red blood cell deformability | 1.70e-04 | 3 | 106 | 2 | MP:0009568 | |
| MousePheno | enhanced coordination | 1.89e-04 | 38 | 106 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 2.09e-04 | 39 | 106 | 4 | MP:0009006 | |
| MousePheno | abnormal synaptic vesicle number | 2.80e-04 | 42 | 106 | 4 | MP:0004792 | |
| MousePheno | abnormal social/conspecific interaction behavior | SPTA1 NBEA AKR1C4 CMYA5 CSMD3 AKR1C1 ADCY3 AKR1C2 STX1A SLC12A2 AKR1C3 | 3.45e-04 | 421 | 106 | 11 | MP:0002557 |
| MousePheno | abnormal stride length | 3.91e-04 | 82 | 106 | 5 | MP:0012690 | |
| MousePheno | abnormal synaptic vesicle recycling | 5.10e-04 | 21 | 106 | 3 | MP:0004770 | |
| MousePheno | abnormal circulating progesterone level | 5.50e-04 | 50 | 106 | 4 | MP:0005184 | |
| MousePheno | abnormal Wallerian degeneration | 5.61e-04 | 5 | 106 | 2 | MP:0010653 | |
| MousePheno | abnormal synaptic vesicle morphology | 5.93e-04 | 51 | 106 | 4 | MP:0004769 | |
| MousePheno | abnormal oligodendrocyte morphology | 5.93e-04 | 51 | 106 | 4 | MP:0000953 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.30e-07 | 10 | 120 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.30e-07 | 10 | 120 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.30e-07 | 10 | 120 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 3.30e-07 | 10 | 120 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.30e-07 | 10 | 120 | 4 | IPR020471 | |
| Domain | - | 2.78e-06 | 16 | 120 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.62e-06 | 17 | 120 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 3.62e-06 | 17 | 120 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.62e-06 | 17 | 120 | 4 | IPR001395 | |
| Domain | - | 3.16e-04 | 21 | 120 | 3 | 3.30.230.10 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 3.64e-04 | 22 | 120 | 3 | IPR014721 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.02e-03 | 69 | 120 | 4 | IPR020636 | |
| Domain | P-loop_NTPase | RAB35 MYH4 MYH8 SPG7 MYO1E DHX38 RAB3D MSH3 RRAD GSPT1 LONP1 GFM1 RAB3B SMC1B | 1.09e-03 | 848 | 120 | 14 | IPR027417 |
| Domain | A2M_N_2 | 1.12e-03 | 8 | 120 | 2 | SM01359 | |
| Domain | - | 1.12e-03 | 8 | 120 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.12e-03 | 8 | 120 | 2 | SM01361 | |
| Domain | A2M | 1.12e-03 | 8 | 120 | 2 | SM01360 | |
| Domain | Ribosomal_S5_D2-typ_fold | 1.34e-03 | 34 | 120 | 3 | IPR020568 | |
| Domain | G_TR_CS | 1.43e-03 | 9 | 120 | 2 | IPR031157 | |
| Domain | A2M | 1.78e-03 | 10 | 120 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.78e-03 | 10 | 120 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.78e-03 | 10 | 120 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.78e-03 | 10 | 120 | 2 | PF07677 | |
| Domain | A2M_comp | 1.78e-03 | 10 | 120 | 2 | PF07678 | |
| Domain | A2M_N | 1.78e-03 | 10 | 120 | 2 | PF01835 | |
| Domain | A2M_N | 1.78e-03 | 10 | 120 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.78e-03 | 10 | 120 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.78e-03 | 10 | 120 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.78e-03 | 10 | 120 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.78e-03 | 10 | 120 | 2 | IPR001599 | |
| Domain | Myosin_head_motor_dom | 1.85e-03 | 38 | 120 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.85e-03 | 38 | 120 | 3 | PS51456 | |
| Domain | Myosin_head | 1.85e-03 | 38 | 120 | 3 | PF00063 | |
| Domain | MYSc | 1.85e-03 | 38 | 120 | 3 | SM00242 | |
| Domain | - | 2.59e-03 | 12 | 120 | 2 | 1.50.10.20 | |
| Domain | G_TR_1 | 3.05e-03 | 13 | 120 | 2 | PS00301 | |
| Domain | - | RAB35 SPG7 MYO1E DHX38 RAB3D MSH3 RRAD GSPT1 LONP1 GFM1 RAB3B SMC1B | 3.09e-03 | 746 | 120 | 12 | 3.40.50.300 |
| Domain | Myosin_N | 4.07e-03 | 15 | 120 | 2 | PF02736 | |
| Domain | Myosin_N | 4.07e-03 | 15 | 120 | 2 | IPR004009 | |
| Domain | IGc2 | 4.13e-03 | 235 | 120 | 6 | SM00408 | |
| Domain | Ig_sub2 | 4.13e-03 | 235 | 120 | 6 | IPR003598 | |
| Domain | Small_GTP-bd_dom | 4.49e-03 | 167 | 120 | 5 | IPR005225 | |
| Domain | Sushi | 4.55e-03 | 52 | 120 | 3 | PF00084 | |
| Domain | CCP | 5.05e-03 | 54 | 120 | 3 | SM00032 | |
| Domain | A/G_cyclase_CS | 5.23e-03 | 17 | 120 | 2 | IPR018297 | |
| Domain | SUSHI | 5.60e-03 | 56 | 120 | 3 | PS50923 | |
| Domain | Myosin_tail_1 | 5.86e-03 | 18 | 120 | 2 | PF01576 | |
| Domain | Myosin_tail | 5.86e-03 | 18 | 120 | 2 | IPR002928 | |
| Domain | EFTu-like_2 | 5.86e-03 | 18 | 120 | 2 | IPR004161 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.86e-03 | 18 | 120 | 2 | IPR008930 | |
| Domain | - | 5.86e-03 | 18 | 120 | 2 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 5.86e-03 | 18 | 120 | 2 | IPR029787 | |
| Domain | GTP_EFTU_D2 | 5.86e-03 | 18 | 120 | 2 | PF03144 | |
| Domain | G_TR_2 | 5.86e-03 | 18 | 120 | 2 | PS51722 | |
| Domain | Sushi_SCR_CCP_dom | 5.88e-03 | 57 | 120 | 3 | IPR000436 | |
| Domain | PH_dom-like | 6.26e-03 | 426 | 120 | 8 | IPR011993 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 2.18e-07 | 9 | 93 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 2.18e-07 | 9 | 93 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 5.65e-07 | 11 | 93 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.21e-06 | 13 | 93 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.21e-06 | 13 | 93 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.69e-06 | 14 | 93 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.69e-06 | 14 | 93 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.69e-06 | 14 | 93 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.69e-06 | 14 | 93 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 2.29e-06 | 15 | 93 | 4 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.43e-05 | 23 | 93 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.43e-05 | 23 | 93 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.43e-05 | 23 | 93 | 4 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.22e-05 | 28 | 93 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.27e-05 | 33 | 93 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.27e-05 | 33 | 93 | 4 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.97e-04 | 44 | 93 | 4 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.15e-04 | 45 | 93 | 4 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.15e-04 | 45 | 93 | 4 | MM14751 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.00e-04 | 49 | 93 | 4 | MM15186 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 3.50e-04 | 51 | 93 | 4 | M29854 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 4.68e-04 | 55 | 93 | 4 | M14933 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 6.47e-04 | 26 | 93 | 3 | MM15297 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.95e-04 | 61 | 93 | 4 | MM14861 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 7.25e-04 | 27 | 93 | 3 | M27586 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.54e-10 | 4 | 124 | 4 | 10500239 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.54e-10 | 4 | 124 | 4 | 14967952 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.54e-10 | 4 | 124 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.54e-10 | 4 | 124 | 4 | 31479646 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16191478 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 15577209 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10702227 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.54e-10 | 4 | 124 | 4 | 29764944 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17888864 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17442338 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 28329705 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 19237748 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 28259989 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16511129 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 7789999 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.54e-10 | 4 | 124 | 4 | 16508162 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 15222881 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17629694 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10526179 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16018803 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.54e-10 | 4 | 124 | 4 | 18667791 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 21521174 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 8274401 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.54e-10 | 4 | 124 | 4 | 34590152 | |
| Pubmed | CFH EPRS1 DMXL2 WASL WDR4 MYO1E CLIP2 NBEA MSH3 ZFC3H1 CMYA5 TRIP11 YWHAG MPRIP FAIM STX1A DAZAP1 GUCY1B1 AKR1C3 MRPS9 PPME1 KCNQ2 BTRC | 1.63e-10 | 1285 | 124 | 23 | 35914814 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 7.67e-10 | 5 | 124 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 7.67e-10 | 5 | 124 | 4 | 16984997 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 7737980 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 7.67e-10 | 5 | 124 | 4 | 17064890 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 10672042 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 38788959 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 18003893 | ||
| Pubmed | PITPNM2 EPRS1 DMXL2 WASL DNAJC13 CCT3 MYO1E CLIP2 SPTA1 RAB3D NBEA DNAJC6 TRIP11 YWHAG ACTR3 MRPS22 MYEF2 LACTB MPRIP TGM1 LONP1 MRPS9 KCNQ2 | 1.30e-09 | 1431 | 124 | 23 | 37142655 | |
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 19273550 | ||
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 2.30e-09 | 6 | 124 | 4 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 2.30e-09 | 6 | 124 | 4 | 29107092 | |
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 15860270 | ||
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 2.30e-09 | 6 | 124 | 4 | 17255200 | |
| Pubmed | BOC ABRA DMXL2 WASL MYH8 MYOM1 DGKD RRAD CMYA5 TRIP11 AKR1C2 BNIP2 GSDME XIRP2 | 3.20e-09 | 497 | 124 | 14 | 23414517 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 22529366 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 33127481 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 12562828 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 5.34e-09 | 7 | 124 | 4 | 34843575 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 16337335 | ||
| Pubmed | 7.89e-09 | 20 | 124 | 5 | 23636947 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 33584538 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 9224647 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 20837989 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 DNAJC13 CCT3 DHX38 NOB1 DGKD MSH3 LBR YWHAG ACTR3 MYEF2 GSPT1 POLR3A MPRIP TGM1 LONP1 A2ML1 MKI67 POLR1B PHIP BTRC | 1.37e-08 | 1353 | 124 | 21 | 29467282 |
| Pubmed | 1.91e-08 | 9 | 124 | 4 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 3.18e-08 | 10 | 124 | 4 | 36313771 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 4.42e-08 | 3 | 124 | 3 | 31780644 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 13678667 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7626489 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 21232532 | ||
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 25774556 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 7.45e-08 | 12 | 124 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 7.45e-08 | 12 | 124 | 4 | 28893949 | |
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 11682476 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.07e-07 | 13 | 124 | 4 | 15117747 | |
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 24580729 | ||
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 17062636 | ||
| Pubmed | 1.50e-07 | 14 | 124 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 1.50e-07 | 14 | 124 | 4 | 34400844 | |
| Pubmed | DNAJC13 LZTR1 CCT3 NSD2 CALU DHX38 NBEA YWHAG ACTR3 LONP1 SLC12A2 CLTB MKI67 PPME1 UXT PLK4 BTRC | 2.08e-07 | 1049 | 124 | 17 | 27880917 | |
| Pubmed | 3.53e-07 | 17 | 124 | 4 | 32243503 | ||
| Pubmed | EPRS1 DNAJC13 CLIP2 CALU DHX38 ZFC3H1 MRPS22 MPRIP CTCF A2ML1 TPX2 MKI67 MRPS9 PCYT2 POLR1B | 3.78e-07 | 847 | 124 | 15 | 35850772 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 15212687 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 5.72e-07 | 19 | 124 | 4 | 17599069 | |
| Pubmed | 7.13e-07 | 20 | 124 | 4 | 24135228 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 20418484 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 25830658 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 CCT3 DHX38 NOB1 LBR ACTR3 MRPS22 GSPT1 LONP1 SETSIP BTK MKI67 PRKAG1 MRPS9 PPME1 POLR1B AMMECR1 PHIP | 1.06e-06 | 1318 | 124 | 18 | 30463901 |
| Pubmed | 1.21e-06 | 52 | 124 | 5 | 23260145 | ||
| Pubmed | 1.29e-06 | 23 | 124 | 4 | 23685333 | ||
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 19846565 | ||
| Pubmed | EPRS1 DNAJC13 CCT3 MYO1E CALU LBR YWHAG MPRIP LONP1 CTCF PRKAG1 MRPS9 | 1.75e-06 | 601 | 124 | 12 | 33658012 | |
| Pubmed | 1.84e-06 | 25 | 124 | 4 | 26098214 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | WASL DNAJC13 MYO1E NOB1 ZFC3H1 ACTR3 LACTB GSPT1 MPRIP BRCA1 MKI67 POLR1B RAB3B | 2.04e-06 | 724 | 124 | 13 | 36232890 |
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 2.17e-06 | 26 | 124 | 4 | 23892084 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 2.45e-06 | 8 | 124 | 3 | 12634303 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 CCT3 MYO1E DHX38 NOB1 ZFC3H1 YWHAG ACTR3 MRPS22 LACTB MPRIP SETSIP TPX2 MKI67 MRPS9 POLR1B HSPA14 | 2.48e-06 | 1257 | 124 | 17 | 36526897 |
| Pubmed | 2.53e-06 | 27 | 124 | 4 | 17077188 | ||
| Pubmed | 2.53e-06 | 27 | 124 | 4 | 23471215 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 2.53e-06 | 27 | 124 | 4 | 14581517 | |
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 2.95e-06 | 28 | 124 | 4 | 29212953 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 2.95e-06 | 28 | 124 | 4 | 29879378 | |
| Pubmed | 2.95e-06 | 28 | 124 | 4 | 20689807 | ||
| Pubmed | 2.95e-06 | 28 | 124 | 4 | 21820362 | ||
| Interaction | AKR1C4 interactions | 9.08e-08 | 8 | 123 | 4 | int:AKR1C4 | |
| Interaction | RPRD1B interactions | 1.69e-06 | 233 | 123 | 10 | int:RPRD1B | |
| Interaction | AKR1C1 interactions | 5.94e-06 | 20 | 123 | 4 | int:AKR1C1 | |
| Interaction | KCTD13 interactions | PITPNM2 EPRS1 DMXL2 WASL DNAJC13 CCT3 MYO1E CLIP2 SPTA1 RAB3D NBEA DNAJC6 TRIP11 YWHAG ACTR3 MRPS22 MYEF2 LACTB MPRIP TGM1 LONP1 MRPS9 KCNQ2 | 1.07e-05 | 1394 | 123 | 23 | int:KCTD13 |
| Cytoband | 10p15-p14 | 3.82e-07 | 6 | 124 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 4.85e-06 | 90 | 124 | 5 | chr10p15 | |
| Cytoband | 16q22 | 9.58e-04 | 17 | 124 | 2 | 16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 1.58e-03 | 183 | 124 | 4 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 2.14e-03 | 199 | 124 | 4 | chr9q21 | |
| Cytoband | 7q11.23 | 2.36e-03 | 97 | 124 | 3 | 7q11.23 | |
| Cytoband | 10p15.1 | 2.61e-03 | 28 | 124 | 2 | 10p15.1 | |
| Cytoband | 9p12 | 2.80e-03 | 29 | 124 | 2 | 9p12 | |
| GeneFamily | Aldo-keto reductases | 1.06e-06 | 15 | 98 | 4 | 399 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.02e-03 | 9 | 98 | 2 | 1234 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | WDR4 NSD2 SPTA1 DNAJC6 BRCA1 BRCA2 TPX2 MKI67 PPME1 OSBP2 AMMECR1 SKA1 PLK4 | 1.91e-07 | 450 | 122 | 13 | M45747 |
| Coexpression | BAKKER_FOXO3_TARGETS_DN | 2.52e-07 | 188 | 122 | 9 | MM904 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 4.25e-07 | 200 | 122 | 9 | M8959 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 4.25e-07 | 200 | 122 | 9 | M5901 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 7.78e-07 | 37 | 122 | 5 | MM630 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 1.01e-06 | 17 | 122 | 4 | MM826 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.89e-06 | 79 | 122 | 6 | MM535 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 3.81e-06 | 89 | 122 | 6 | MM690 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 4.42e-06 | 24 | 122 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 5.24e-06 | 25 | 122 | 4 | MM480 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | EPRS1 WDR4 CCT3 SPTA1 LBR DNAJC6 YWHAG AKR1C1 MRPS22 GSPT1 BRCA1 BRCA2 AKR1C3 MRPS9 PPME1 OSBP2 AMMECR1 SKA1 PLK4 | 6.57e-06 | 1271 | 122 | 19 | M39197 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.11e-05 | 30 | 122 | 4 | MM853 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | CCT3 MSH3 LBR MRPS22 SLC12A2 BRCA1 BRCA2 CTCF MKI67 POLR1B CARNMT1 SKA1 | 1.13e-05 | 555 | 122 | 12 | M2343 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.19e-05 | 228 | 122 | 8 | MM1014 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.41e-05 | 168 | 122 | 7 | M18811 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.43e-05 | 66 | 122 | 5 | MM631 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 1.65e-05 | 33 | 122 | 4 | M10150 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 1.65e-05 | 33 | 122 | 4 | M1490 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 1.86e-05 | 34 | 122 | 4 | MM1160 | |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | SPTA1 ANKRD20A3P ANKRD20A8P LBR BRCA2 PDIK1L TPX2 MKI67 POLR1B BTRC ANKRD20A1 | 2.16e-05 | 497 | 122 | 11 | MM3640 |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 2.34e-05 | 36 | 122 | 4 | MM3660 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.46e-05 | 183 | 122 | 7 | M2993 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.82e-05 | 187 | 122 | 7 | M2984 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DMXL2 MYO1E AKR1C4 ANKRD20A3P ANKRD20A8P CMYA5 ITGA7 YWHAG AKR1C1 AKR1C2 TAX1BP3 BNIP2 BRCA2 AKR1C3 ANKRD20A1 | 2.85e-05 | 930 | 122 | 15 | MM893 |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 3.12e-05 | 190 | 122 | 7 | MM1311 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 3.12e-05 | 190 | 122 | 7 | M761 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 4.19e-05 | 199 | 122 | 7 | M9410 | |
| Coexpression | HALLMARK_E2F_TARGETS | 4.33e-05 | 200 | 122 | 7 | M5925 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 4.67e-05 | 276 | 122 | 8 | M3063 | |
| Coexpression | EPPERT_PROGENITOR | 4.68e-05 | 138 | 122 | 6 | M19232 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 5.74e-05 | 45 | 122 | 4 | MM1173 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 5.89e-05 | 210 | 122 | 7 | MM958 | |
| Coexpression | GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN | 6.41e-05 | 146 | 122 | 6 | M452 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | WDR4 RAB3D MSH3 LBR TRIP11 POLR3A FAIM DAZAP1 POLR1B SKA1 PLK4 PHIP XPR1 | 6.87e-05 | 776 | 122 | 13 | M1107 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 7.09e-05 | 293 | 122 | 8 | MM895 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 7.67e-05 | 219 | 122 | 7 | MM1237 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NSD2 NBEA MSH3 MAP3K12 MYEF2 STX1A BRCA2 TPX2 MKI67 PPME1 SKA1 PLK4 | 8.14e-05 | 680 | 122 | 12 | MM456 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 8.36e-05 | 300 | 122 | 8 | M39059 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | WDR4 RAB3D MSH3 LBR TRIP11 POLR3A FAIM DAZAP1 POLR1B SKA1 PLK4 PHIP XPR1 | 8.65e-05 | 794 | 122 | 13 | MM982 |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_UP | 1.18e-04 | 54 | 122 | 4 | M1037 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.74e-04 | 111 | 122 | 5 | MM705 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.76e-04 | 426 | 122 | 9 | M9516 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 1.78e-04 | 60 | 122 | 4 | MM847 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 1.79e-04 | 427 | 122 | 9 | M17923 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | EPRS1 NSD2 CALU MSH3 YWHAG GSPT1 FAIM BRCA1 DAZAP1 BRCA2 CTCF TPX2 MKI67 MRPS9 PPME1 SKA1 PLK4 | 1.95e-04 | 1363 | 122 | 17 | M45782 |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 2.01e-04 | 341 | 122 | 8 | M2879 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | EPRS1 WDR4 CALU TRIP11 GSPT1 LONP1 BRCA1 MKI67 MRPS9 GFM1 HSPA14 | 2.16e-04 | 644 | 122 | 11 | M10501 |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 2.22e-04 | 117 | 122 | 5 | M7854 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CFH CCT3 CALU SPTA1 LBR ACTR3 GSPT1 BNIP2 BRCA1 DAZAP1 GUCY1B1 CTCF BTK PRKAG1 AKR1C3 PCYT2 AMMECR1 | 2.65e-04 | 1399 | 122 | 17 | M535 |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 3.06e-04 | 69 | 122 | 4 | MM621 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 3.19e-04 | 196 | 122 | 6 | M8147 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 3.28e-04 | 197 | 122 | 6 | M7403 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 3.46e-04 | 199 | 122 | 6 | M5893 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN | 3.46e-04 | 199 | 122 | 6 | M3588 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 3.46e-04 | 199 | 122 | 6 | M3591 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN | 3.46e-04 | 199 | 122 | 6 | M3594 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 3.46e-04 | 199 | 122 | 6 | M6837 | |
| Coexpression | GSE30083_SP2_VS_SP4_THYMOCYTE_UP | 3.55e-04 | 200 | 122 | 6 | M5034 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_UP | 3.55e-04 | 200 | 122 | 6 | M5054 | |
| Coexpression | GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP | 3.55e-04 | 200 | 122 | 6 | M9437 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN | 3.55e-04 | 200 | 122 | 6 | M4589 | |
| Coexpression | GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 3.55e-04 | 200 | 122 | 6 | M317 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 3.55e-04 | 200 | 122 | 6 | M4805 | |
| Coexpression | GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP | 3.55e-04 | 200 | 122 | 6 | M9254 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_UP | 3.55e-04 | 200 | 122 | 6 | M4471 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP | 3.55e-04 | 200 | 122 | 6 | M5723 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN | 3.55e-04 | 200 | 122 | 6 | M6989 | |
| Coexpression | MATZUK_SPERMATOCYTE | 3.60e-04 | 72 | 122 | 4 | M1831 | |
| Coexpression | MATZUK_SPERMATOCYTE | 3.79e-04 | 73 | 122 | 4 | MM1234 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP | 3.85e-04 | 203 | 122 | 6 | M10184 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL | 3.97e-04 | 476 | 122 | 9 | M45717 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 4.00e-04 | 74 | 122 | 4 | MM769 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | MYOM1 CLIP2 CALU DGKD IGSF10 STX1A MAST4 XIRP2 GUCY1B1 OSBP2 FRMD3 | 4.07e-04 | 694 | 122 | 11 | M45731 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | NBEA CSMD3 DNAJC6 YWHAG AKR1C1 AKR1C2 MYEF2 GSDME RAB3B XPR1 | 4.13e-04 | 584 | 122 | 10 | M39068 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | SPTA1 AKR1C4 LBR EFHB AKR1C1 AKR1C2 DCP1B BTN2A3P AKR1C3 PHIP | 4.13e-04 | 584 | 122 | 10 | MM1080 |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 4.76e-04 | 138 | 122 | 5 | MM1151 | |
| Coexpression | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP | 5.13e-04 | 79 | 122 | 4 | M3737 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 5.23e-04 | 300 | 122 | 7 | M8702 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 5.25e-04 | 141 | 122 | 5 | M2901 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | NSD2 RAB3D LBR YWHAG FAIM SLC12A2 PDIK1L MKI67 OSBP2 C5 AMMECR1 GFM1 | 5.91e-04 | 845 | 122 | 12 | M18090 |
| Coexpression | FISCHER_DREAM_TARGETS | WDR4 NSD2 MSH3 LBR LONP1 BRCA1 BRCA2 CTCF TPX2 MKI67 DZIP3 SKA1 PLK4 | 5.93e-04 | 969 | 122 | 13 | M149 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 5.94e-04 | 612 | 122 | 10 | M4772 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | SASH1 MYO1E PDGFRL SPTA1 CMYA5 ITGA7 DNAJC6 TGM1 BRCA2 GUCY1B1 TPX2 C5 FRMD3 | 6.16e-04 | 973 | 122 | 13 | M41080 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 6.21e-04 | 404 | 122 | 8 | M19488 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MDGA2 NBEA CSMD3 DNAJC6 YWHAG AKR1C1 AKR1C2 MAST4 PDIK1L RAB3B CSGALNACT1 FRMD3 IGSF3 XPR1 | 6.43e-04 | 1106 | 122 | 14 | M39071 |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 6.76e-04 | 85 | 122 | 4 | MM802 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 6.95e-04 | 150 | 122 | 5 | MM936 | |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_2500_k-means-cluster#2 | CAMK1D WDR4 SPTA1 ANKRD20A3P LBR PDIK1L TPX2 MKI67 AKR1C3 MRPS9 PCYT2 OSBP2 TTC13 AMMECR1 SKA1 PLK4 BTRC PGBD2 | 7.99e-06 | 957 | 121 | 18 | PP_RBC_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DMXL2 MYH8 DNAJC13 CCT3 DGKD GSDME MAST4 SLC12A2 BRCA1 BRCA2 PDIK1L DZIP3 CARNMT1 CSGALNACT1 BTRC SMC1B | 8.66e-06 | 776 | 121 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 7.13e-05 | 122 | 121 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | Stem Cells, SC.CMP.BM, Lineage- Kit+ Sca1- CD34+ FcgRlow, Bone marrow, avg-2 | 8.60e-05 | 317 | 121 | 9 | GSM791117_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | SPTA1 DNAJC6 BRCA1 BRCA2 TPX2 MKI67 POLR1B CARNMT1 AMMECR1 PLK4 | 1.01e-04 | 401 | 121 | 10 | GSM791108_500 |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.53e-08 | 182 | 124 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.93e-08 | 184 | 124 | 8 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.03e-08 | 199 | 124 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.39e-08 | 200 | 124 | 8 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.39e-08 | 200 | 124 | 8 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.39e-08 | 200 | 124 | 8 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-07 | 174 | 124 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-07 | 174 | 124 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.37e-07 | 176 | 124 | 7 | 98814f0a67411b2f7b25dc489b2aadb77f45a853 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-07 | 180 | 124 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-07 | 180 | 124 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 8.58e-07 | 184 | 124 | 7 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 8.90e-07 | 185 | 124 | 7 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 8.90e-07 | 185 | 124 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 8.90e-07 | 185 | 124 | 7 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.57e-07 | 187 | 124 | 7 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.57e-07 | 187 | 124 | 7 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.57e-07 | 187 | 124 | 7 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.57e-07 | 187 | 124 | 7 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-07 | 187 | 124 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-07 | 187 | 124 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-06 | 189 | 124 | 7 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.06e-06 | 190 | 124 | 7 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 1.10e-06 | 191 | 124 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 124 | 7 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 124 | 7 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-06 | 193 | 124 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-06 | 194 | 124 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 1.22e-06 | 194 | 124 | 7 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.22e-06 | 194 | 124 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 194 | 124 | 7 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-06 | 194 | 124 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-06 | 194 | 124 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-06 | 194 | 124 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-06 | 195 | 124 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.27e-06 | 195 | 124 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.27e-06 | 195 | 124 | 7 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-06 | 196 | 124 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.31e-06 | 196 | 124 | 7 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.35e-06 | 197 | 124 | 7 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.35e-06 | 197 | 124 | 7 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.35e-06 | 197 | 124 | 7 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.40e-06 | 198 | 124 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.40e-06 | 198 | 124 | 7 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.40e-06 | 198 | 124 | 7 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.40e-06 | 198 | 124 | 7 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.45e-06 | 199 | 124 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.45e-06 | 199 | 124 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 199 | 124 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-06 | 199 | 124 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 1.45e-06 | 199 | 124 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-06 | 199 | 124 | 7 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 199 | 124 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-06 | 199 | 124 | 7 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.45e-06 | 199 | 124 | 7 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class | 1.45e-06 | 199 | 124 | 7 | 2508c55f9ffe17b694c70f1283f41ad4a8e83c00 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.45e-06 | 199 | 124 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.45e-06 | 199 | 124 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 1.45e-06 | 199 | 124 | 7 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-06 | 200 | 124 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-06 | 200 | 124 | 7 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-06 | 200 | 124 | 7 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-06 | 200 | 124 | 7 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-06 | 200 | 124 | 7 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-06 | 200 | 124 | 7 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-06 | 200 | 124 | 7 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-T/NK_proliferative|Bac-SEP / Disease, condition lineage and cell class | 1.50e-06 | 200 | 124 | 7 | a09b4e07b273880e94032b939ab191caaf6d656e | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-06 | 200 | 124 | 7 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative|Influenza_Severe / Disease, condition lineage and cell class | 1.50e-06 | 200 | 124 | 7 | e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.50e-06 | 200 | 124 | 7 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.50e-06 | 200 | 124 | 7 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 200 | 124 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-06 | 200 | 124 | 7 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-06 | 167 | 124 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-06 | 167 | 124 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.43e-06 | 167 | 124 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-06 | 168 | 124 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 169 | 124 | 6 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 169 | 124 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.80e-06 | 172 | 124 | 6 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.71e-06 | 175 | 124 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.71e-06 | 175 | 124 | 6 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 177 | 124 | 6 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 177 | 124 | 6 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 177 | 124 | 6 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 179 | 124 | 6 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 179 | 124 | 6 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 179 | 124 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 179 | 124 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| Drug | cloxazolam | 7.85e-10 | 4 | 122 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 7.85e-10 | 4 | 122 | 4 | ctd:D011278 | |
| Drug | tetralol | 7.85e-10 | 4 | 122 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 7.85e-10 | 4 | 122 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 3.91e-09 | 5 | 122 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 3.91e-09 | 5 | 122 | 4 | ctd:C010092 | |
| Drug | Medazepam | 1.17e-08 | 6 | 122 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 5.40e-08 | 8 | 122 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 9.68e-08 | 9 | 122 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 9.68e-08 | 9 | 122 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 1.50e-07 | 3 | 122 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.50e-07 | 3 | 122 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.50e-07 | 3 | 122 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.50e-07 | 3 | 122 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.50e-07 | 3 | 122 | 3 | ctd:C530610 | |
| Drug | octyl gallate | 1.61e-07 | 10 | 122 | 4 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 2.52e-07 | 11 | 122 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 2.52e-07 | 11 | 122 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 3.76e-07 | 12 | 122 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 5.40e-07 | 13 | 122 | 4 | CID000050096 | |
| Drug | flunisolide | 5.40e-07 | 13 | 122 | 4 | ctd:C007734 | |
| Drug | tetrahydrodeoxycorticosterone | 5.98e-07 | 4 | 122 | 3 | ctd:C009413 | |
| Drug | gliquidone | 5.98e-07 | 4 | 122 | 3 | ctd:C010969 | |
| Drug | DBD-H | 5.98e-07 | 4 | 122 | 3 | CID000131382 | |
| Drug | 5-alpha-Dihydroprogesterone | 7.54e-07 | 14 | 122 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 7.54e-07 | 14 | 122 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 7.54e-07 | 14 | 122 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 1.49e-06 | 5 | 122 | 3 | CID000257630 | |
| Drug | oxcarbazepine | 2.86e-06 | 19 | 122 | 4 | ctd:C036006 | |
| Drug | AC1L93E5 | 2.97e-06 | 6 | 122 | 3 | CID000412383 | |
| Drug | Estazolam | 2.97e-06 | 6 | 122 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 2.97e-06 | 6 | 122 | 3 | CID000439898 | |
| Drug | Glipizide | 2.97e-06 | 6 | 122 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 2.97e-06 | 6 | 122 | 3 | ctd:C023723 | |
| Drug | benzo(a)pyrene-7,8-dione | 3.56e-06 | 20 | 122 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 3.56e-06 | 20 | 122 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 4.38e-06 | 21 | 122 | 4 | ctd:D005445 | |
| Drug | 4-hydroxyequilenin-o-quinone | 5.17e-06 | 7 | 122 | 3 | ctd:C117714 | |
| Drug | zomepirac | 5.17e-06 | 7 | 122 | 3 | ctd:C020549 | |
| Drug | benzene dihydrodiol | 5.33e-06 | 22 | 122 | 4 | CID000000418 | |
| Drug | Glycyrrhetinic Acid | 7.67e-06 | 24 | 122 | 4 | ctd:D006034 | |
| Drug | 2-cyclohexen-1-ol | 8.24e-06 | 8 | 122 | 3 | CID000013198 | |
| Drug | 9,10-phenanthrenequinone | 9.10e-06 | 25 | 122 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 9.10e-06 | 25 | 122 | 4 | ctd:D011280 | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 7323_DN | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 2.21e-05 | 31 | 122 | 4 | ctd:C017228 | |
| Drug | flufenamic acid | 2.56e-05 | 108 | 122 | 6 | CID000003371 | |
| Drug | alpha-methylcinnamic acid | 2.85e-05 | 2 | 122 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.85e-05 | 2 | 122 | 2 | DB07768 | |
| Drug | baccharin | 2.85e-05 | 2 | 122 | 2 | ctd:C012764 | |
| Drug | chlordecone | 3.01e-05 | 67 | 122 | 5 | CID000000299 | |
| Drug | fenamic acid | 3.19e-05 | 12 | 122 | 3 | ctd:C001209 | |
| Drug | methylparaoxon | 3.19e-05 | 12 | 122 | 3 | ctd:C008480 | |
| Drug | olaparib | 3.19e-05 | 12 | 122 | 3 | ctd:C531550 | |
| Drug | blebbistatin | 3.84e-05 | 116 | 122 | 6 | CID003476986 | |
| Drug | 4-formyl-benzoate | 4.13e-05 | 13 | 122 | 3 | CID000012088 | |
| Drug | Diazepam | 4.88e-05 | 74 | 122 | 5 | ctd:D003975 | |
| Drug | Dydrogesterone | 5.23e-05 | 14 | 122 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 5.23e-05 | 14 | 122 | 3 | CID000631219 | |
| Drug | AC1L1BWR | 5.55e-05 | 76 | 122 | 5 | CID000001642 | |
| Drug | 20 alpha-dihydroprogesterone | 6.18e-05 | 40 | 122 | 4 | CID000008956 | |
| Drug | drospirenone | 6.52e-05 | 15 | 122 | 3 | ctd:C035144 | |
| Drug | o-quinone | 6.82e-05 | 41 | 122 | 4 | CID000011421 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.78e-05 | 191 | 122 | 7 | 2137_UP | |
| Drug | 9-cis-retinal | 7.99e-05 | 16 | 122 | 3 | ctd:C031390 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 2865_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 1821_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3629_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; PC3; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 7142_UP | |
| Drug | benzo(a)pyrene-1,6-quinone | 9.66e-05 | 17 | 122 | 3 | ctd:C030233 | |
| Drug | arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 443_UP | |
| Drug | Flufenamic Acid | 9.86e-05 | 45 | 122 | 4 | ctd:D005439 | |
| Drug | AC1L9IXX | 9.86e-05 | 45 | 122 | 4 | CID000446000 | |
| Drug | naphthalene-1,2-dihydrodiol | 9.86e-05 | 45 | 122 | 4 | CID000000362 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 6963_DN | |
| Drug | chlorpropamide; Down 200; 100uM; MCF7; HG-U133A | 1.04e-04 | 200 | 122 | 7 | 141_DN | |
| Drug | cloxazolam | 1.15e-04 | 18 | 122 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 1.15e-04 | 18 | 122 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 1.15e-04 | 18 | 122 | 3 | ctd:C018003 | |
| Drug | Flavonoids | MYH8 CLIP2 LBR ITGA7 ACTR3 MPRIP TGFBR3 TGM1 STX1A SLC12A2 BRCA1 PTPRQ PRKAG1 PCYT2 POLR1B GFM1 RAB3B | 1.19e-04 | 1136 | 122 | 17 | ctd:D005419 |
| Drug | KU55933 | 1.27e-04 | 48 | 122 | 4 | CID005278396 | |
| Drug | AC1L8ZBW | 1.37e-04 | 19 | 122 | 3 | CID000435356 | |
| Drug | androstane-3,17-dione | 1.61e-04 | 51 | 122 | 4 | CID000000443 | |
| Drug | Polymyxin M | 1.70e-04 | 4 | 122 | 2 | CID000197072 | |
| Drug | LY254155 | 1.86e-04 | 21 | 122 | 3 | CID009803760 | |
| Drug | coniferaldehyde | 1.86e-04 | 21 | 122 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 1.86e-04 | 21 | 122 | 3 | ctd:D000068538 | |
| Drug | Db04047 | 1.86e-04 | 21 | 122 | 3 | CID000151434 | |
| Drug | Hexestrol | 2.17e-04 | 55 | 122 | 4 | ctd:D006589 | |
| Drug | 3-hydroxyandrostan-17-one | 2.24e-04 | 102 | 122 | 5 | CID000000225 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 2.46e-04 | 23 | 122 | 3 | DB03461 | |
| Drug | 1,2-dihydroxynaphthalene | 2.49e-04 | 57 | 122 | 4 | CID000011318 | |
| Drug | phenolphthalein | 2.66e-04 | 58 | 122 | 4 | CID000004764 | |
| Drug | NSC36919 | 2.66e-04 | 58 | 122 | 4 | CID000235496 | |
| Drug | medazepam | 2.80e-04 | 24 | 122 | 3 | CID000004041 | |
| Drug | farnesal | 2.82e-04 | 5 | 122 | 2 | ctd:C084519 | |
| Drug | NSC9700 | BOC MYH4 MYH8 CLIP2 AKR1C4 AKR1C1 ADCY3 AKR1C2 GSDME AKR1C3 POLR1B | 2.83e-04 | 578 | 122 | 11 | CID000005408 |
| Drug | tricarballylate | 2.84e-04 | 59 | 122 | 4 | CID000014925 | |
| Disease | Neoplasms, Hormone-Dependent | 6.23e-08 | 3 | 118 | 3 | C0027661 | |
| Disease | Hermaphroditism | 6.20e-07 | 5 | 118 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 6.20e-07 | 5 | 118 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 6.20e-07 | 5 | 118 | 3 | C0033804 | |
| Disease | Intersex Conditions | 6.20e-07 | 5 | 118 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 6.20e-07 | 5 | 118 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 2.16e-06 | 7 | 118 | 3 | C0036875 | |
| Disease | colorectal carcinoma (is_marker_for) | 1.45e-05 | 37 | 118 | 4 | DOID:0080199 (is_marker_for) | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 1.59e-05 | 2 | 118 | 2 | C1839840 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 1.59e-05 | 2 | 118 | 2 | cv:C1839840 | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 1.59e-05 | 2 | 118 | 2 | C4749652 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 1.59e-05 | 2 | 118 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 1.59e-05 | 2 | 118 | 2 | 614279 | |
| Disease | C5a anaphylatoxin measurement | 4.74e-05 | 3 | 118 | 2 | EFO_0020208 | |
| Disease | brother of CDO measurement | 4.74e-05 | 3 | 118 | 2 | EFO_0020194 | |
| Disease | Hereditary breast ovarian cancer syndrome | 9.46e-05 | 4 | 118 | 2 | cv:C0677776 | |
| Disease | Dwarfism | 1.34e-04 | 25 | 118 | 3 | C0013336 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 1.57e-04 | 5 | 118 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | cortolone glucuronide (1) measurement | 2.35e-04 | 6 | 118 | 2 | EFO_0800552 | |
| Disease | Adult only | 2.35e-04 | 6 | 118 | 2 | C3842001 | |
| Disease | Neoplastic Cell Transformation | 2.46e-04 | 139 | 118 | 5 | C0007621 | |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 4.37e-04 | 8 | 118 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | Intellectual Disability | 4.46e-04 | 447 | 118 | 8 | C3714756 | |
| Disease | epilepsy (implicated_via_orthology) | 5.12e-04 | 163 | 118 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 5.60e-04 | 9 | 118 | 2 | C2931038 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.95e-04 | 41 | 118 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.95e-04 | 41 | 118 | 3 | C0858252 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 6.99e-04 | 10 | 118 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | susceptibility to measles measurement | 1.00e-03 | 49 | 118 | 3 | EFO_0008414 | |
| Disease | Abruptio Placentae | 1.02e-03 | 12 | 118 | 2 | EFO_1001754 | |
| Disease | Mouth Diseases | 1.02e-03 | 12 | 118 | 2 | C0026636 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Varicose veins | 1.09e-03 | 193 | 118 | 5 | HP_0002619 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.20e-03 | 13 | 118 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Benign tumor of pancreas | 1.20e-03 | 13 | 118 | 2 | C0347284 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.20e-03 | 13 | 118 | 2 | C1846647 | |
| Disease | abdominal fat cell number | 1.23e-03 | 198 | 118 | 5 | EFO_0021534 | |
| Disease | skin melanoma (is_implicated_in) | 1.40e-03 | 14 | 118 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | C-C motif chemokine 19 measurement | 1.40e-03 | 14 | 118 | 2 | EFO_0008047 | |
| Disease | early cardiac repolarization measurement | 1.40e-03 | 14 | 118 | 2 | EFO_0004885 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.40e-03 | 14 | 118 | 2 | C0677776 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.61e-03 | 15 | 118 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Endometrial Neoplasms | 1.64e-03 | 58 | 118 | 3 | C0014170 | |
| Disease | response to methotrexate | 1.83e-03 | 16 | 118 | 2 | GO_0031427 | |
| Disease | Antibody Deficiency Syndrome | 2.07e-03 | 17 | 118 | 2 | C0003257 | |
| Disease | breast carcinoma (is_marker_for) | 2.37e-03 | 66 | 118 | 3 | DOID:3459 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 2.58e-03 | 142 | 118 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.59e-03 | 19 | 118 | 2 | C3501846 | |
| Disease | Pancreatic carcinoma | 2.59e-03 | 19 | 118 | 2 | C0235974 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.59e-03 | 19 | 118 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 2.59e-03 | 19 | 118 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 2.59e-03 | 19 | 118 | 2 | C0587248 | |
| Disease | Adenocarcinoma of prostate | 2.87e-03 | 20 | 118 | 2 | C0007112 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.92e-03 | 71 | 118 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 3.04e-03 | 72 | 118 | 3 | C0476089 | |
| Disease | BREAST CANCER | 3.17e-03 | 21 | 118 | 2 | 114480 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.17e-03 | 21 | 118 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | Nystagmus | 3.17e-03 | 21 | 118 | 2 | HP_0000639 | |
| Disease | Seckel syndrome | 3.48e-03 | 22 | 118 | 2 | C0265202 | |
| Disease | LEOPARD Syndrome | 3.48e-03 | 22 | 118 | 2 | C0175704 | |
| Disease | complement factor H-like 1 protein measurement | 3.48e-03 | 22 | 118 | 2 | EFO_0600092 | |
| Disease | Immunologic Deficiency Syndromes | 3.80e-03 | 23 | 118 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGYSVSREKKERFSL | 81 | A0A5B6 | |
| GVVSIKEDKYFQTSR | 806 | Q5TYW2 | |
| EQKEEYRGRTTFVSK | 86 | Q96KV6 | |
| EKRATVVESSEKAYS | 141 | P61981 | |
| DGSVKREDIFYTSKL | 71 | P17516 | |
| VDEKGRVVDIYSKFD | 231 | P54619 | |
| KIADGTVKREEIFYT | 71 | Q5T2L2 | |
| STYRDIVVKKEDGFT | 281 | Q9Y6F8 | |
| GVVSIKEDKYFQTSR | 806 | Q5CZ79 | |
| KREGKSFIYQSEVSF | 3301 | Q7Z407 | |
| EESETFIKGKERKTY | 11 | P49711 | |
| YGFKVEVEKESVLST | 371 | Q8N4J0 | |
| TERDKGTLYELTFKG | 216 | Q8TDX6 | |
| VRDSSKAGKYTVSVF | 306 | Q06187 | |
| DGSVKREDIFYTSKL | 71 | P42330 | |
| VVVESDFVKYEGKFA | 71 | O60443 | |
| DKYIVSASGDRTIKV | 436 | Q9Y297 | |
| GYSDVKFTVTLETKD | 46 | A8K2U0 | |
| KTGVVRYVGETDFAK | 231 | Q9UDT6 | |
| TKEEIVDKYDLFVGS | 286 | O43852 | |
| KQKLYSRTGESVEFV | 1186 | P08603 | |
| AKETVTVGKDGTRDY | 1406 | Q8TDJ6 | |
| ETELREYFKKFGVVT | 126 | Q96EP5 | |
| ERKVVETEDAYKFAG | 126 | Q15286 | |
| FVSTVGIDFKVKTVY | 51 | P20337 | |
| FVSTVGIDFKVKTVY | 51 | O95716 | |
| KYVAKELAVRTFEVT | 186 | Q14739 | |
| ETGKDTFRVYKSGSE | 61 | Q9Y570 | |
| VIVYSVTDKGSFEKA | 166 | P55042 | |
| GVVSIKEDKYFQTSR | 806 | Q5SQ80 | |
| GDVTYSFRKVRDKIS | 306 | Q9Y5G9 | |
| AVTEFYAKDTVDIKG | 471 | P20585 | |
| VRVESGYFSLEKTKQ | 261 | Q6WCQ1 | |
| EYVRLVTEFSKKTGD | 61 | Q9ULX3 | |
| TYEERVGFKKSRDVF | 351 | Q8N653 | |
| FPEKEYEGEKVSVTT | 196 | P83111 | |
| IEFSYELSKVEGKTG | 386 | Q92993 | |
| AKTSVFVAEPKESYV | 36 | P13535 | |
| ITLTVDGRDTYEEVK | 116 | Q99447 | |
| VFSTIKEYEKSSEGA | 111 | O43526 | |
| SVEERKAKFTFLYVG | 336 | O96028 | |
| SEDGYRTVVQGTKKE | 311 | Q14332 | |
| RKSAYKIVSGEAESV | 721 | P36776 | |
| TDSRKNPFVYKVETV | 461 | Q02153 | |
| GDFKEISSVKLVSRY | 201 | P46013 | |
| KFSIDIETFYKTDAG | 106 | Q9BZ72 | |
| SYFSKEAARKVTGVV | 721 | Q969R2 | |
| AGKVTTDYGETEKER | 736 | Q86Y13 | |
| KGKTVEVGRAYFETE | 136 | P15170 | |
| TKFGEGDSTIRVIKY | 721 | Q7Z553 | |
| TEGKTKFSGNEEIYI | 1871 | Q9UMZ3 | |
| GVVKVDYGDVSVRKT | 386 | Q8IUC8 | |
| KVSGVKVYTFDERIE | 1016 | Q9BXP8 | |
| SVESNIEDKIFGKTY | 451 | P38398 | |
| EKTDVEGTLFVYTRS | 51 | Q8IZD4 | |
| FRYSGKVAKEVVEAS | 331 | A2A2Y4 | |
| KETGTLYASKFEDVL | 111 | P0CF75 | |
| GVVSIKEDKYFQTSR | 806 | Q5VUR7 | |
| AISKKEFSIDVGYER | 261 | P61158 | |
| FIISKTTREDAGKYR | 2396 | Q6WRI0 | |
| YKLAEEVSGRTEVTV | 796 | O75054 | |
| VEITGLEKGTSYKFR | 666 | Q9BWV1 | |
| TTGTFVEEITENYKR | 1301 | P51587 | |
| KEDFSTTGTAYFEVK | 206 | P01031 | |
| ISEVSREDYGKKEIS | 2281 | Q8N3K9 | |
| TSGKRVVYVDGKEEI | 26 | Q9NVQ4 | |
| KGDLDFTYVTSRIIV | 61 | O75061 | |
| FEDNIKISVYTGKSE | 166 | Q8IZF7 | |
| EAISYVREKTKTGVD | 396 | O60266 | |
| RKGSITEYTAAEEKE | 111 | Q12982 | |
| IEFIKGQVRKYSSTE | 296 | O75165 | |
| YDDVVKISDFGTSKE | 246 | Q12852 | |
| VYPKAVERSSTFENK | 1576 | O15021 | |
| ARVGKAYEKTTESSE | 516 | Q16760 | |
| FGTAVIKEYSAKDVV | 386 | Q8N7U6 | |
| SERDVGSKVKYEVTV | 876 | Q13683 | |
| KVYFDTENKETVISG | 481 | Q96RP9 | |
| EKKGYRTDATVSVFL | 406 | Q9UKG4 | |
| GKLRYEIDTGEETKF | 96 | Q0VDF9 | |
| KILEGTETTKYVFTD | 146 | P82650 | |
| TEKEKFAGGDYTTTI | 1211 | P07814 | |
| ETKDTKGRYFIVEAD | 201 | Q96BD8 | |
| KGRYFIVEADIKEFT | 206 | Q96BD8 | |
| EVTYVELFKDAEGKS | 126 | Q9P2K5 | |
| YSEAKEVRGVKVFRS | 531 | Q9BXS9 | |
| YGTEEDVVKSKKTFR | 2101 | Q8NFP9 | |
| FIDTETKKELLGSYV | 256 | Q8N165 | |
| TYEVEKTLGIEAART | 1251 | O14802 | |
| TKVEVTEFEDIKSGY | 131 | P0DME0 | |
| EYKKGESQTDIEITR | 246 | P49368 | |
| EIKKIGDEYFTFITD | 351 | P49368 | |
| TSVFVVDPKESYVKA | 36 | Q9Y623 | |
| YIDEIDAVGKKRSTT | 406 | Q9UQ90 | |
| DEAKTGSTYIFFTEK | 156 | Q15198 | |
| TEDFIQVIEKTGKSY | 736 | O00444 | |
| VEKGFYTEKDASTLI | 111 | Q8IU85 | |
| LREEGTKYKSFVQTA | 261 | Q9BSK2 | |
| KTVVSKTYERGGDVS | 111 | Q8N0Z2 | |
| DGSVKREDIFYTSKL | 71 | Q04828 | |
| DGSVKREDIFYTSKL | 71 | P52895 | |
| IEFINEKGSKRTATY | 241 | Q9Y4X0 | |
| GYVASEEAFVKESKE | 171 | P09497 | |
| KGVKATGTVREYRTE | 366 | Q6P3X8 | |
| DREGSYHEVTTVKKE | 1151 | A4UGR9 | |
| VTDEDTVKRYFAKFE | 41 | Q9UBH6 | |
| KDQGKEYDGFTITIT | 681 | Q8NBP0 | |
| EATGEKVLRYETFIS | 11 | Q9UBK9 | |
| TAKGEEEIKTYRSEE | 741 | Q8WWQ0 | |
| VPTSKRETYTEDFIK | 61 | P82933 | |
| KIIYVEESGEEKTFA | 81 | Q8NDV3 | |
| VDYVERAVSDTKKAV | 241 | Q16623 | |
| AVVTYTAESKGVVKF | 271 | P55011 | |
| FSEDKTDKGIYVTRV | 46 | O14907 | |
| KVGTFKFIYVDVLSE | 601 | O94885 | |
| VTEDGKVDYRTEQKF | 491 | Q92620 | |
| KGVSEETLKEFSTIY | 2266 | P02549 | |
| EKIVETYRGKETEYQ | 1466 | Q15643 | |
| GSFKIVYVEEKAIGT | 511 | P22735 | |
| KVLVADKSGDVYSFS | 116 | P57081 | |
| TSKVIYDFIEKTGGV | 251 | O00401 | |
| GSVYKSEFIDLSEKI | 771 | Q9H9Y6 | |
| SIIKTYEIFETSDGR | 71 | Q96PF2 | |
| EITASAEKYVEKLFG | 1236 | O60293 | |
| KEYGAVTSFTELKIA | 166 | Q03167 | |
| QGKKRTFDETVSTYV | 311 | Q9ULW0 | |
| FADTVTKYDRRFKGV | 766 | Q12965 | |
| SVVVKRYKGEFDETR | 366 | P52179 |